When is desmopressin (DDAVP) contraindicated for the treatment of von Willebrand disease (vWD) type 2?

Updated: Dec 30, 2019
  • Author: Eleanor S Pollak, MD; Chief Editor: Srikanth Nagalla, MBBS, MS, FACP  more...
  • Print
Answer

DDAVP trials may be contraindicated in patients with type 2B, because of thrombocytopenia and possible thrombotic complications. DDAVP is usually not effective in patients with type 2M and is rarely effective in patients with type 2N.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!